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CNS	 and	 to	 get	 reactivated	 by	 antigen-presenting	 cells	 (APCs)	 in	 order	 to	 induce	
inflammation	 in	experimental	autoimmune	encephalomyelitis	 (EAE),	an	animal	model	of	
MS.	The	contributions	of	macrophages	and	dendritic	cells	as	APCs	at	the	border	between	
CNS	 and	 periphery	were	 shown.	 However,	 antigen	 presentation	 in	 CNS	 remains	 largely	
undefined;	especially	the	function	of	glia	cells	as	APCs	remains	elusive.		
Microglia	are	the	only	CNS-resident	immune	cells,	thus	their	potential	function	in	regulating	
T	 cell	 activation	 cannot	 be	 overlooked.	 In	 this	 study,	we	determined	 to	 understand	 the	
relationship	between	microglia	and	T	cells.	Live	 imaging	revealed	that	naive	microglia	or	




GFP	 cells	 and	 TOVA-NFAT-GFP	 cells	 even	without	 the	 presence	 of	 cognate	 antigen,	 indicating	
antigen-independent	T	cell	activation	by	microglia,	which	are	regulated	by	IFN-γ.	In	addition,	
by	 comparing	macrophages	 and	microglia	 in	 the	CNS	of	 rats	with	 EAE,	we	 showed	 that	


















of	 EAE,	we	performed	RNA-sequencing	 analysis.	 Compared	 to	naive	microglia,	microglia	
from	 EAE	 rats	 showed	 strong	 enrichment	 of	 genes	 associated	 with	 IFN-γ	 signaling,	
suggesting	 that	 microglia	 are	 influenced	 by	 TH1	 cells.	 Moreover,	 microglia	 strongly	
upregulated	chemokines	such	as	Cxcl9,	Cxcl10,	Cxcl11	and	Ccl5	which	are	important	for	T	




can	 regulate	 T	 cell	 differentiation	 and	 activation	 antigen-independently.	 Although	
macrophages	showed	higher	T	cell	activating	capacity,	their	number	is	low	at	early	stages	
of	 EAE.	 At	 that	 time	 point,	 microglia	 can	 stimulate	 T	 cells	 and	 induce	 production	 of	













ZNS	 infiltrieren	und	dort	 durch	Antigen-präsentierende	 Zellen	 (APCs)	 reaktiviert	werden	
müssen,	um	eine	Entzündung	auszulösen.	Makrophagen	und	Dendritische	Zellen	sind	an	
diesem	 Prozess	 an	 der	 Grenze	 zwischen	 ZNS	 und	 Peripherie	 beteiligt.	 Dennoch	 ist	 die	












stimulierte	 Mikroglia	 hin.	 Desweiteren	 zeigte	 sich	 im	 Vergleich	 von	 Makrophagen	 und	
Mikroglia	aus	dem	ZNS	von	Ratten	mit	EAE,	dass	Makrophagen	effizientere	APCs	sind.	Die	
Kapazität	 von	 Mikroglia	 von	 Ratten	 mit	 EAE,	 T-Zellen	 zu	 aktivieren,	 ähnelte	 der	
Aktivierungskapazität	 von	 IFN-γ-stimulierten	Mikroglia	 aus	naiven	Tieren.	Die	Expression	
von	IFN-γ,	einem	charakteristischen	Zytokin	der	TH1-Zellen,	wurde	sowohl	in	MBP-	als	auch	













Neben	 Mikroglia	 wurden	 auch	 Astrozyten	 auf	 ihre	 Fähigkeit,	 T-Zellen	 zu	 aktivieren,	
untersucht	und	als	weniger	potent	identifiziert.		
Durch	 Transkriptomanalysen	 wurden	 die	 Expressionsprofile	 von	 Mikroglia	 und	
Makrophagen	im	Anfangsstadium	der	EAE	charakterisiert.	Im	Vergleich	zu	naiven	Mikroglia	
exprimieren	Mikroglia	aus	Ratten	mit	beginnender	EAE	in	erhöhtem	Maße	Gene,	die	mit	
der	 Antwort	 auf	 IFN-γ	 assoziiert	 sind,	 was	 auf	 eine	 Kommunikation	 von	 Th1-Zellen	mit	
Mikroglia	 hindeutet.	 Außerdem	exprimieren	Mikroglia	 aus	 Ratten	mit	 EAE	 höhere	 Level	
verschiedener	Chemokine,	z.B.	Cxcl9,	Cxcl10,	Cxcl11	und	Ccl5,	die	für	die	Rekrutierung	von	
T-Zellen	 in	das	ZNS	wichtig	sind.	Obwohl	Makrophagen	effizienter	darin	sind,	T-Zellen	zu	
stimulieren,	 sind	Mikroglia	 zunächst	 die	 einzigen	myeloiden	 Zellen	 im	 ZNS,	 die	 T-Zellen	
aktivieren	können,	bevor	Makrophagen	infiltrieren.		
Diese	 Studie	 konnte	 zeigen,	 dass	 Mikroglia	 neben	 Antigen-abhängigen	 Prozessen	 auch	
Antigen-unabhängige	 Mechanismen	 nutzen,	 um	 die	 T-Zell-Differenzierung	 und	 –
Aktivierung	 zu	 regulieren.	Makrophagen	 haben	 zwar	 eine	 höhere	 Kapazität,	 T-Zellen	 zu	
aktivieren,	infiltrieren	das	ZNS	jedoch	zu	einem	späteren	Zeitpunkt	als	die	ersten	T-Zellen.	
Zu	Beginn	der	EAE	sind	also	nur	Mikroglia	anwesend,	die	die	T-Zellen	stimulieren	und	die	
Produktion	 proinflammatorischer	 Zytokine	 induzieren.	 Außerdem	 produzieren	Mikroglia	












































































Bar-Or	 et	 al.	 2018).	 Three	 different	 categories	 of	 MS	 have	 been	 defined	 in	 order	 to	
standardize	the	terminology	used	for	describing	the	disease	patterns	of	MS	since	Charcot	
firstly	 named	 MS	 in	 1868,	 which	 include	 relapsing-remitting	 MS	 (RRMS),	 secondary	
progressive	MS	 (SPMS)	 and	 primary	 progressive	MS	 (PPMS)	 (Lublin	 and	 Reingold	 1996,	
Lublin,	Reingold	et	al.	2014).	Patients	with	RRMS	are	clinically	characterized	by	self-limited	
episodes	of	acute	neurologic	dysfunctions,	such	as	sensory	disturbances	and	optic	neuritis	







infections	 (Ascherio	 and	 Munger	 2007),	 the	 exact	 cause	 for	 MS	 is	 unknown.	 The	




The	 traditional	 view	 is	 that	 adaptive	 immune	 response	 plays	 a	 pivotal	 role	 in	 the	
pathogenesis	of	MS.	It	is	suggested	that	myelin-specific	autoreactive	lymphocytes,	mostly	
T	helper	(TH)	cells,	are	primed	in	the	periphery	and	activated	in	the	CNS	after	crossing	the	
BBB	which	 further	 leads	to	the	 formation	of	 local	 inflammatory	demyelinating	 lesions	 in	
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CNS	 (Stys,	 Zamponi	 et	 al.	 2012,	 Ciccarelli,	 Barkhof	 et	 al.	 2014).	 Indeed,	 a	 genome-wide	
association	study	on	a	big	cohort	of	MS	patients	demonstrated	 that	 the	majority	of	 risk	
genes	related	to	the	disease	are	associated	with	TH	cells	(Cotsapas	and	Mitrovic	2018).	In	
contrast	to	CD8+	T	cells,	TH	cells	are	unlikely	to	kill	oligodendroglia	directly	or	cause	axonal	











periplaque	 areas.	 The	 cluster	 of	 activated	 microglia	 in	 periplaque	 regions	 is	 frequently	
observed,	 where	 they	 partially	 surround	 myelin	 sheaths	 and	 degenerating	 axons.	 In	
addition,	the	engagement	of	microglia	together	with	the	complement	component	C3d	in	
disrupted	myelin	segments	has	been	proposed	as	the	source	of	MS	antigens	(Prineas,	Kwon	
et	 al.	 2001).	 However,	 the	majority	 of	 phagocytic	 cells	 presented	 in	 the	 demyelinating	
center	of	active	 lesions	are	macrophages	 (Lassmann	2018).	Due	to	 limited	availability	of	
sophisticated	methods	to	distinguish	between	infiltrated	macrophages	and	microglia,	the	
exact	function	played	by	each	cell	type	remains	to	be	further	defined.	In	general,	in	active	
MS	 lesions,	 phagocytes	 produce	 high	 amounts	 of	 pro-inflammatory	 cytokines,	 such	 as	
tumor	necrosis	factor	alpha	(TNF-a),	chemokines	and	vasoactive	substances	to	accelerate	
the	 progress	 of	 inflammation	 (Codarri,	 Greter	 et	 al.	 2013).	 In	 addition,	 phagocytes	 can	
produce	 neurotoxic	 oxidation	 products	 such	 as	 reactive	 oxygen	 species	 and	 glutamate,	
which	potentially	contribute	to	demyelination	and	axon	damage	(Nikic,	Merkler	et	al.	2011).	





as	 atrophy,	 microglia	 activation	 and	 axonal	 injury,	 in	 normal-appearing	 gray	 and	 white	
matter	 (Kutzelnigg,	 Lucchinetti	 et	 al.	 2005).	Due	 to	 a	 lack	of	 suitable	 animal	models	 for	




It	 has	 been	 known	 that	 only	 humans	 can	 develop	 MS	 (Bove	 2018),	 thereby	 no	




virus	 vaccine	developed	neuroparalytic	 complications.	 The	 inoculum	 for	 the	 rabies	 virus	
vaccination	was	prepared	 from	 rabbit	 spinal	 cord,	which	was	 contaminated	with	neural	
elements.	Back	then,	it	was	not	clear	whether	the	rabies	virus	or	the	neural	elements	caused	
the	 neurological	 dysfunction.	 The	 issue	 was	 addressed	 later	 on	 after	 administrating	














and	 biological	 factors	 in	 EAE	 (Constantinescu,	 Farooqi	 et	 al.	 2011).	 The	major	 common	
feature	between	active	EAE	and	MS	is	the	formation	of	demyelination,	whereas	passive	EAE	
reproduces	 the	 neuroinflammatory	 features	 of	 MS	 patients	 including	 macrophage	
accumulation	and	CD4+	T	cell	infiltration	(Lassmann	and	Bradl	2017).	The	main	difference	
between	EAE	and	MS	is	that	EAE	requires	an	external	trigger,	such	as	immunization	with	
myelin	antigen	or	 transfer	of	encephalitogenic	T	 cells,	 to	 initiate	 the	disease	 (Ransohoff	
2012).	In	addition,	in	EAE	the	neuroinflammation	mainly	occurs	in	spinal	cord,	whereas	in	
MS	 the	 neuroinflammation	 prominently	 present	 in	 cerebellar	 and	 cerebral	 cortex	
(Ransohoff	2012).	Importantly,	none	of	the	EAE	models	can	perfectly	mimic	all	the	courses	
of	MS,	which	limits	their	usage	in	revealing	the	whole	picture	of	the	pathogenesis	of	MS.	








































lymphatic	drainage	 in	 the	CNS	parenchyma	(Louveau,	Herz	et	al.	2018).	However,	 in	 the	







two-photon	 imaging	 showed	 that	 intraparenchymal	 extracellular	 proteins	 exit	 the	
parenchyma	through	perivascular	efflux	into	the	cerebrospinal	fluid	(CSF)	(Iliff,	Wang	et	al.	
2012),	while	the	CSF	was	found	to	exit	the	CNS	via	arachnoid	granulations	into	the	sinus	
lumen	 (Go,	 Houthoff	 et	 al.	 1986).	 Those	 studies	 suggested	 the	 existence	 of	 routes	 that	
permit	the	CNS	to	communicate	with	the	peripheral	immune	system.		
Recent	 studies	 showed	 that	 the	 CNS	 is	 not	 an	 immune-free	 organ.	 Single	 cell	 analyses	
revealed	 that	 a	 complex	 and	 abundant	 immune	 cell	 landscape	 exists	 in	 CNS	 border	
interfaces,	which	 includes	 dendritic	 cells	 (DCs),	 border-associated	macrophages	 (BAMs),	
innate	 lymphoid	 cells,	monocytes,	 T	 cells	 and	granulocytes	 (Goldmann,	Wieghofer	et	 al.	














Encephalitogenic	 T	 cells	 that	have	 lost	 the	 tolerance	 to	CNS-specific	 antigen,	 and	hence	
induce	an	immune	response	in	the	CNS	as	a	driver	of	MS	have	been	tremendously	discussed.	
CD4+	and	CD8+	T	cells	are	found	within	the	CNS	lesions	as	well	as	in	the	CSF	of	MS	patients	





regulated	 neuroinflammation:	 (i)	 recognition	 of	 antigen	 and	 activation	 of	 T	 cells	 in	 the	
periphery;	 (ii)	 infiltration	 into	 the	 CNS;	 and	 (iii)	 inflammatory	 cascade	 initiation	 and	
recruitment	of	other	leukocytes	(Codarri,	Greter	et	al.	2013).		
It	 is	 not	 yet	 conclusive	 how	 neuroantigen-reactive	 CD4+	 T	 cells	 get	 activated	 and	
experienced	with	CNS	antigens	in	the	periphery.	One	possible	explanation	is	that	CD4+	T	cell	
activation	is	triggered	while	the	body	mounts	an	immune	defense	against	pathogens,	such	
as	 human	 herpesvirus	 and	 Epstein-Barr	 virus,	 which	may	 have	 a	 structural	 similarity	 to	
neuronal	antigens	(Challoner,	Smith	et	al.	1995,	Wandinger,	Jabs	et	al.	2000).	Secondary	
lymphoid	 organs	 have	 been	 considered	 as	 the	 places	where	 TH	 cells	 encounter	 cognate	
antigens	presented	by	 antigen-presenting	 cells	 (APCs).	 Additionally,	 the	 T	 cell	 activation	
may	occur	in	gut-associated	lymphoid	tissue	in	microbiota	dependent	manner	(Berer,	Mues	
et	al.	 2011).	Upon	activation,	TH	 cells	 could	obtain	 the	ability	 to	 cross	 the	BBB	 (Codarri,	
Greter	et	al.	2013).		










(VLA)-4	 and	 vascular	 cell	 adhesion	 protein	 1	 (VCAM-1)	 dependent	 manner	 (Vajkoczy,	
Laschinger	et	al.	2001,	Bartholomaus,	Kawakami	et	al.	2009,	Schlager,	Korner	et	al.	2016,	
Kyratsous,	Bauer	et	al.	2017).	In	addition,	the	β-synuclein-specific	T	cells,	which	were	found	
to	 induce	 autoimmune	 lesions	 in	 cortex,	 penetrate	 into	 the	 CNS	 by	 using	 this	
leptomeningeal	 route	 (Lodygin,	 Hermann	 et	 al.	 2019).	 It	 has	 been	 proposed	 that	 the	
molecular	 mechanism	 behind	 T	 cell	 infiltration	 is	 depending	 on	 the	 nature	 of	 the	
lymphocyte	(Engelhardt	and	Ransohoff	2012).	For	instance,	in	spinal	cord	microvessels	of	
mice,	 interferon-γ	 (IFN-γ)	 producing	 TH1	 cells	 cross	 the	 BBB	 in	 a	 VLA-4	 dependent	way	
(Vajkoczy,	Laschinger	et	al.	2001,	Glatigny,	Duhen	et	al.	2011,	Rothhammer,	Heink	et	al.	
2011),	while	 in	 the	CP	vessels	 IL-17-producing	TH17	cells	enter	 the	CNS	 in	a	 lymphocyte	
function-associated	 antigen	 1	 (LFA-1)	 dependent	 manner	 (Reboldi,	 Coisne	 et	 al.	 2009,	
Rothhammer,	Heink	et	al.	2011).	
Once	 neuroantigen-reactive	 TH	 cells	 pass	 through	 the	 BBB,	 they	 may	 encounter	 their	
cognate	antigen	presented	by	 local	APCs,	which	 further	 starts	 a	process	of	 immune	cell	





This	 is	 further	 supported	 by	 a	 study	 using	mouse	 EAE	 which	 showed	 silencing	 TH1	 cell	
polarizing	 cytokine	 IL-18	 and	 IL-12	 protected	 the	 mice	 from	 developing	 EAE	 (Leonard,	
Waldburger	et	al.	1995,	Shi,	Takeda	et	al.	2000).	Moreover,	adoptive	transfer	of	TH1	cells	is	
sufficient	to	induce	EAE	(Domingues,	Mues	et	al.	2010).	Over	decades,	TH1	cells	have	been	








signature	 cytokines	 alone	 is	 indispensable	 for	 the	 development	 of	 EAE	 (Kreymborg,	
Etzensperger	et	al.	2007,	Sonderegger,	Kisielow	et	al.	2008,	Haak,	Croxford	et	al.	2009).	
Nowadays	 it	 is	 accepted	 that	 multiple	 pathways	 participate	 in	 the	 development	 of	
neuroinflammation.	Both	TH1	and	TH17	cells	are	able	to	initiate	the	encephalomyelitis	with	








suggested	 that	 APCs	 are	 also	 critical	 for	 initiating	 and	 progressing	 the	 autoimmune	
responses	 (Mundt,	Mrdjen	 et	 al.	 2019).	 APCs	 can	 deliver	 three	 signals	 to	 T	 cells	 during	
immune	reaction,	which	are	important	for	antigen-specific	T	cell	activation	(Fig.	1.3.1).	The	
first	signal	is	that	APCs	present	antigens	through	major	histocompatibility	complex	class	II	





















are	 speculated	 as	 potential	 nonimmune	 APCs	 given	 their	 ability	 in	 T	 cell	 reactivation.	
However,	under	homeostasis	in	the	CNS,	none	of	these	cells	express	MHCII	and	their	roles	






express	MHCII	under	homeostatic	 conditions	 (Van	Hove,	Martens	et	al.	 2019).	Although	
mature	macrophages	express	molecules	required	for	antigen	presentation,	such	as	Cd74,	
H2-Aa	 and	 H2-Ab1	 encoded	 MHC	 II	 related	 proteins,	 and	 can	 interact	 with	 T	 cells,	
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to	 enable	 their	 invasion	 into	 CNS	 (Greter,	 Heppner	 et	 al.	 2005).	 In	 addition,	 specific	
depletion	of	MHCII	in	conventional	DCs	(cDCs)	prevented	the	development	of	autoimmune	
neuroinflammation	 in	 the	 Zbtb46Cre	 Iabfl/fl	 mouse	 induced	 by	 myelin	 oligodendrocyte	
glycoprotein	35-55	epitope	(MOG35-55)	(Mundt,	Mrdjen	et	al.	2019).	Therefore,	the	cDCs,	







Microglia	 are	 the	 only	 innate	 immune	 cells	 in	 CNS	 parenchyma	 under	 steady	 state	
conditions	and	constitute	5-10%	of	all	brain	cells	(Aguzzi,	Barres	et	al.	2013).	 It	has	been	
considered	 that	 microglia	 play	 a	 key	 role	 in	 maintaining	 the	 homeostasis	 of	 CNS	 by	
constantly	surveying	the	microenvironment	via	dynamically	retracting	and	extending	the	
highly	 ramified	 processes	 (Nimmerjahn,	 Kirchhoff	 et	 al.	 2005).	 Therefore,	microglia	 can	
detect	the	subtle	changes	and	thereby	respond	accordingly	through	a	variety	of	cell	surface	
receptors,	 such	 as	 fractalkine-	 and	 purino-receptors,	 Toll-like	 receptors	 (TLRs),	
phosphatidylserine	and	lipid	receptors	and	triggering	receptor	expressed	on	myeloid	cells	2	
(TREM2)	(Arcuri,	Mecca	et	al.	2017).	Activated	microglia	exert	neuroprotective	as	well	as	
neurotoxic	 functions	 in	 the	 CNS.	 Microglia	 exhibit	 neuroprotective	 roles	 by	 removing	
neuronal	cell	bodies,	producing	anti-inflammatory	cytokines	such	as	transforming	growth	
factor	 b	 (TGF-b)	 and	 IL-10	 (Wolf,	 Boddeke	 et	 al.	 2017).	 Unhinged	 activated	 microglia	
















parenchyma	 from	 the	 infiltrated	monocytes	 are	 based	 on	 the	 expression	 of	 CD11b	 and	
CD45,	 that	 CD11b+CD45high	 indicates	monocytes	 and	 CD11b+CD45low	 indicates	microglia.	
However,	 due	 to	 lack	 of	 sophisticated	 methods	 to	 distinguish	 resident	 microglia	 from	
infiltrated	macrophages	in	vivo	and	difficulty	in	culturing	primary	microglia,	the	early	studies	
showed	inconsistent	results	about	their	role	in	EAE.	For	example,	Williams	et	al.’s	in	vitro	
study	 showed	 that	 microglia	 from	 allogeneic	 donors	 are	 capable	 of	 inducing	 T	 cell	
proliferation	(Williams,	Ulvestad	et	al.	1993),	whereas	Carson	et	al.	showed	that	microglia	
cannot	induce	T	cell	proliferation	(Carson,	Sutcliffe	et	al.	1999).	
Since	 microglia	 can	 uptake	 antigens,	 it	 can	 be	 speculated	 that	 they	 function	 as	 APCs.	
Therefore,	other	efforts	have	been	devoted	to	discovering	the	antigen	presentation	ability	
of	microglia,	given	that	in	some	rodents	like	Lewis	rats,	up	to	5%	microglia	express	MHCII	










cells	 meet	 microglia	 and	 interact	 through	 receptors	 and	 cytokines,	 which	 further	 lead	 to	
neurodegeneration	 and	 demyelination.	 In	 the	 red	 and	 blue	 boxes	 listed	 currently	 approved	
therapeutic	 strategies	 that	 target	 at	 T	 cell	 and	microglia	 interactions	 outside	 or	 inside	 the	 CNS.	
(Adopted	from	(Dong	and	Yong	2019).	License	ID:	4997551421262).	
induce	the	engraftment	of	monocyte	into	CNS.	Microglia	and	engrafted	monocytes	were	








microglia	 are	 activated	 and	 express	 a	 similar	 profile	 of	 effector	molecules	 as	 infiltrated	
macrophages	 and	 also	 exhibit	 similar	 antigen	 presentation	 abilities	 (Mack,	 Vanderlugt-
Castaneda	 et	 al.	 2003).	 In	 addition,	with	 the	multistep	 activation	 by	GM-CSF	 and	 IFN-γ,	
microglia	acquire	the	APC	function	efficiently	(Matyszak,	Denis-Donini	et	al.	1999).	Despite	
of	controversial	data	on	microglia	functioning	as	APCs,	microglia	do	interact	with	T	cells	and	
induce	upregulation	of	 IL-10	 in	both	T	cells	and	microglia,	 implying	an	anti-inflammatory	
role	of	microglia	in	MS	patients	(Chabot,	Williams	et	al.	1999).	However,	microglia	can	also	
contribute	to	the	inflammation.	For	example,	MBP-primed	T	cells	can	markedly	induce	the	
expression	 of	 inducible	 nitric	 oxide	 synthase	 (iNOS)	 and	 production	 of	 nitric	 oxide	 in	
microglia	 (Dasgupta,	 Jana	 et	 al.	 2002),	 which	 further	 supports	 the	 idea	 that	 microglia	
crosstalk	with	T	cells.	
More	studies	on	the	relationship	between	microglia	and	TH1	cells	suggest	 that	microglia	
play	a	 role	 in	amplifying	neuroinflammation	during	EAE.	For	 instance,	 IFN-γ	can	activate	






Platten	 and	 Steinman	 2005).	 Therefore,	 during	 EAE	 development,	 after	 the	 peripherally	
primed	T	cells	infiltrated	into	the	CNS,	microglia	potentially	receive	the	signals	from	T	cells	
which	contribute	to	the	formation	of	the	inflammatory	cascade.		
Finally,	 microglia	 depletion	 by	 using	 CD11b-HSVTK	 transgenic	 mice	 and	 bone	 marrow	












As	described	above,	 the	 role	of	microglia	 in	MS/EAE	 is	contradictory	and	still	one	of	big	
remaining	 questions.	 It	 seems	 decisively	 important	 to	 understand	 the	 contribution	 of	
microglia	 in	EAE	development	especially	whether	microglia	 instruct	T	cells	to	 initiate	the	
neuroinflammation.		
1.3.4 Cytokine	networks	in	MS/EAE	
Cytokines,	which	 include	 lymphokines,	 chemokines,	growth	 factors	and	 IFNs,	enable	 the	
communication	between	different	cells	(Becher,	Spath	et	al.	2017).	Clinical	studies	revealed	
that	the	abnormal	production	of	certain	cytokines	such	as	IFN-γ,	TNF-a,	IL-1b,	IL-6,	GM-CSF,	
and	 the	 IFN-γ-inducible	 protein	 of	 10	 kDa	 (IP-10)	 correlates	 with	 the	 intensity	 of	
neuroinflammation	in	MS	patients	(Traugott	and	Lebon	1988,	Maimone,	Gregory	et	al.	1991,	













cytokine	 production	 by	 CNS-resident	 cells,	 which	 in	 turn	 induce	 more	 recruitment	 of	
leukocytes,	thus	fueling	the	formation	of	massive	inflammatory	reaction	(Goverman	2009).		
IL-6	and	 IL-1	are	both	 important	 in	generating	 the	pathogenic	 function	of	TH	cells	 in	 the	
periphery	 as	well	 as	 in	 the	CNS.	 IL-6	promotes	differentiating	 TH17	 cells	 to	 acquire	pro-
inflammatory	 effector	 functions	 and	 suppresses	 regulatory	 functions	 by	 preventing	 the	












(Chung,	 Chang	 et	 al.	 2009).	 In	 addition,	 IL-1	 signaling	was	 shown	 to	 be	 critical	 for	 pre-







pro-IL-1b	 in	 spinal	 cord	 and	 IL-1b	 knockout	 in	 CD4+	 T	 cells	 protected	 the	 mice	 from	










cytokine.	On	 the	one	hand,	administrating	 IFN-γ	 into	CNS	 induced	 inflammation,	on	 the	
other	 hand	 applying	 IFN-γ-blocking	 antibodies	 exacerbated	 the	 progress	 of	 EAE	 (Billiau,	
























of	 blood	 samples	 showed	 enhanced	 expression	 of	 TNF	 and	 IFN-γ	 in	MS	 patients	 (Beck,	
Rondot	 et	 al.	 1988,	 Rieckmann,	 Albrecht	 et	 al.	 1995).	 TNF	 can	 induce	 oligodendrocyte	
apoptosis	 and	 decrease	 glutamate	 uptake	 by	 astrocytes,	 which	 may	 contribute	 to	





some	 patients	 who	 have	 inflammatory	 arthritis	 caused	 the	 formation	 of	 demyelinating	




EAE	development	 (Hovelmeyer,	Hao	 et	 al.	 2005,	 Steeland,	 Van	Ryckeghem	et	 al.	 2017),	
suggesting	 a	 pathogenic	 role	 of	 TNFR1.	 In	 contrast,	 TNFR2	 signaling	 contributes	 to	
remyelination	 by	 regulating	 the	 differentiation	 and	 proliferation	 of	 oligodendrocyte	
progenitor	 cells	 in	a	 cuprizone	model	of	demyelination	 (Arnett,	Mason	et	al.	2001),	and	
TNFR2	deficiency	exaggerated	EAE	development	(Suvannavejh,	Lee	et	al.	2000),	suggesting	
a	 protective	 role	 of	 TNFR2.	 Taken	 together,	 TNF	 exerts	 complex	 effects	 in	 CNS	
autoimmunity	that	varies	depending	on	the	binding	receptor.	
GM-CSF	was	 initially	 recognized	as	hematopoietic	growth	 factor	ascribed	 to	 its	ability	 in	




CSF	 knockout	 mice	 are	 resistant	 to	 EAE	 development	 with	 failure	 of	 immune	 cells	 to	
infiltrate	 the	 CNS	 and	 less	 proliferation	 of	 antigen-specific	 splenocytes	 (McQualter,	
Darwiche	et	al.	2001),	thus	revealing	a	crucial	role	of	GM-CSF	in	CNS	autoimmune	disorders.	
Since	then,	tremendous	attention	has	been	paid	to	find	out	the	GM-CSF	network	and	its	





detected	and	mainly	confined	to	nonsterile	 tissues	 like	gut,	skin	and	 lung	(Hamilton	and	
Achuthan	 2013).	 However,	 it	 is	 still	 not	 fully	 understood	 which	 factors	 induce	 the	
production	of	GM-CSF	 in	TH	cells.	At	 least,	 it	was	shown	that	 IL-23-stimulated	TH17	cells	
produce	GM-CSF,	thus	GM-CSF	was	considered	as	a	TH17	related	cytokine	(El-Behi,	Ciric	et	
al.	2011).	Later,	fate-mapping	of	GM-CSF	expression	showed	GM-CSF	was	not	restricted	to	
TH17	 cells.	 A	 discrete	 encephalitogenic	 TH	 subset	 was	 shown	 to	 account	 for	 GM-CSF	
production	in	an	IL-23	receptor	and	an	IL-1	receptor	signaling	dependent	manner,	and	the	
vast	majority	of	 those	cells	 co-expressed	TNF,	 IL-2	and	 IFN-γ	 instead	of	 IL-17	 (Komuczki,	
Tuzlak	 et	 al.	 2019).	 Ablating	 GM-CSF-producing	 TH	 cells	 attenuated	 EAE	 development	
without	affecting	IFN-γ	+	T	cell	and	IL-17A+	T	cell	infiltration	into	the	CNS,	which	indicates	
that	GM-CSF	defines	the	pathogenicity	of	TH	cells	(Galli,	Hartmann	et	al.	2019,	Komuczki,	
Tuzlak	 et	 al.	 2019),	 which	 could	 contribute	 to	 the	 mechanism	 how	 CNS-infiltrating	
leukocytes	damage	the	CNS	in	MS.		




DCs	 (King,	 Kroenke	 et	 al.	 2010)	 have	 been	 implicated	 in	 playing	 a	 GM-CSF	 dependent	
pathogenic	 role	 in	 autoimmune	 disease.	 However,	 specific	 knockout	 of	 the	 GM-CSF	



















cells,	 NFAT	 remains	 as	 a	 highly	 phosphorylated	 form	 and	 locates	 in	 the	 cytosol.	 After	
antigen-dependent	 activation,	 TCR	 ligation	 triggers	 receptor-associated	 tyrosine	 kinase	
activation	 which	 further	 induces	 the	 activation	 of	 phospholipase	 C-γ.	 Activated	
phospholipase	 C-γ	 causes	 phosphatidylinositol-4,5-bisphosphate	 hydrolyzation	 to	
diacylglycerol	 and	 inositol-1,4,5-trisphosphate	 (InsP3),	which	 induces	 the	 release	 of	 Ca2+	
from	its	intracellular	store	in	endoplasmic	reticulum	(ER).	The	emptying	of	Ca2+	stores	in	the	
ER	triggers	the	opening	of	Ca2+	channels	in	the	plasma	membrane,	which	induces	the	influx	
of	 extracellular	 Ca2+	 resulting	 further	 increase	 of	 intracellular	 Ca2+	 concentrations.	 The	
increased	 Ca2+	 binds	 to	 calmodulin,	 which	 induces	 calcineurin	 activation.	 Activated	
calcineurin	dephosphorylates	NFAT	and	causes	NFAT	translocation	into	the	nucleus,	where	
NFAT	regulates	the	expression	of	T	cell	activation	related	genes	(Macian	2005).	
A	 truncated	 NFAT	 fused	 to	 GFP	 (ΔNFAT-GFP),	 which	 keeps	 the	 function	 of	 calcineurin	
interaction	 and	 nucleus	 translocation	 but	 lacks	 its	 binding	 ability	 to	 DNA	 (Pesic,	


















parenchyma.	 Experimental	 studies	 showed	 that,	 T	 cell	 activation	 in	 CNS	 leads	 to	 the	
inflammatory	cascade	initiation	and	other	leukocytes	recruitment.	Thus,	it	is	important	to	
understand	 how	 T	 cells	 get	 activated	 and	 the	 mechanism	 behind	 their	 pathogenicity	





We	 hypothesize	 that	 before	 onset	 of	 EAE,	 microglia	 instruct	 T	 cells	 to	 acquire	 their	
pathogenicity,	which	is	crucial	for	further	infiltration	of	peripheral	lymphocytes.		
Firstly,	 we	 will	 establish	 primary	 adult	 microglia	 culture	 and	 T	 cell/microglia	 co-culture	
system.	Then	we	will	use	live	imaging	to	visualize	whether	microglia	induce	T	cell	activation	
in	vitro.	Here	we	will	co-culture	primary	microglia	with	TMBP-NFAT-GFP	cells	and	TOVA-NFAT-GFP	
cells,	 which	 are	 engineered	 with	 T	 cell	 activation	 indicator.	 By	 using	 this	 method,	 the	
activation	of	T	cells	can	be	recorded	and	tracked	in	real	time.	





potential	 pathways	which	 are	 responsible	 for	microglia	 and	 T	 cell	 interaction	 and	 their	
activation.	







































Horse	serum	 50	ml	 PAA	 Laboratories,	B15-027	
PMA	 stimulated	 EL4	 IL2	
supernatant	 10	ml	 -	


























































solution	 -	 -	 Sigma,	A6964	
Table	2.1.1I	Reagents,	buffers	and	media	for	cell	culture.	








Bacto	agar	 15	g	 Fisher	 scientific,	10455513	
Ampicillin	 100	mg/L	 Sigma,	A0166	
Table	2.1.2I	Reagents,	buffers	and	media	for	bacteria	culture,	DNA	extraction.	














































































































































































NT	 Non-targeting	 -	 -	 GCTGCATGGGGCGCGAATCA	
Table	2.1.5I	sgRNA	used	for	Tnf,	Il1b	and	Il1r1	knockout.		
2.1.5 Antibodies,	cell	dyes,	cytokines,	stimulators,	conjugates	
Name	 Clone,	isotype	 Company,	cat	no.	 Applications	
Mouse	anti-rat	Iba1		 1022-5,	IgG2b	 Santa	Cruz	Biotechnology,		sc-32725	 Histology	





















































PerCP	streptavidin	 -	 Jackson	 ImmunoResearch,	016120084	 Flowcytometry	




Streptavidin-HRP	 -	 SouthernBiotech,	7105-05	 ELISA	

















































NucleoBond®	Xtra	Midi	EF	 Macherey-Nagel,	740420.50		 Plasmid	 DNA	purification	
QIAprep	Spin	Miniprep	Kit	 Qiagen,	27104	 Plasmid	 DNA	purification	
Agilent	RNA	6000	Pico	Reagents	 Agilent	Technologies,	5067-1513	 RNA	quality	evaluation	















tissue	 was	 dissociated	 mechanically	 in	 Falcon®	 100	 µm	 cell	 strainers	 in	 cold	 PBS	 by	
















































































The	 spleen	was	 taken	 out	 of	 the	 rat	 and	was	 put	 into	 cold	 PBS.	 To	 obtain	 a	 single	 cell	
suspension,	the	spleen	was	homogenized	on	a	cell	strainer.	Then	the	cell	suspension	was	





A	 maximum	 1	 ×	 106	 cells	 were	 transferred	 into	 a	 96-well	 V-bottom	 plate	 and	 were	
centrifuged	 at	 400	g,	 4	 °C	 for	 3	min	 followed	by	washing	with	 100	µl/well	 FACS	 buffer.	
Primary	 antibodies	 were	 applied	 at	 a	 dilution	 of	 1:100	 in	 100	µl	 FACS	 buffer	 and	were	
incubated	for	30	min	on	ice.	Three	washing	steps	with	100	µl/well	FACS	buffer	were	applied	


































were	kept	 for	10	min	 for	T	 cells	 to	 settle	before	 live	 imaging.	The	 interactions	between	
microglia	 and	 TMBP-NFAT-GFP	 or	 TOVA-NFAT-GFP	 cells	 were	 recorded	 for	 30	min	 with	 a	 30	 sec	
interval.	
Imaging	of	CNS-infiltrated	phagocytes	and	T	cells	
Imaging	 of	 phagocytes	 and	 TMBP-NFAT-GFP	 or	 TOVA-NFAT-GFP	 cells	 in	 a	 co-culture	 system.	
Phagocytes	were	isolated	from	the	CNS	of	rats	with	tEAE	on	day	4	after	transfer	of	TMBP	cells	
by	running	Percoll	gradients	in	the	same	ways	as	for	microglia	isolation.	The	clinical	scores	









the	Percoll	 gradients,	 the	microglia/macrophage-enriched	 interphase	was	 taken	out	and	
stained	 for	 CD45	 and	 CD11b.	 400	 µl	 sorting	 buffer	 were	 used	 to	 resuspend	 the	 cells.	
CD11b+CD45high	(macrophage)	and	CD11b+CD45low	(microglia)	populations	were	sorted	by	
using	a	BD	FACSAria	 IIIu	cell	 sorter.	Around	100,000	 infiltrated	macrophages	or	 resident	
microglia	were	sorted	from	one	EAE	rat.	Macrophages	and	microglia	were	plated	on	two	



















at	 room	 temperature.	 The	 plate	 was	 washed	 with	 300	 µl/well	 PBST	 for	 five	 times.	
Streptavidin-HRP	was	applied	1:4000	 in	blocking	buffer,	100	µl/well	 for	30	min	at	 room	
temperature.	The	plate	was	washed	with	300	µl/well	PBST	for	three	times.	100	µl/well	TMB	
substrate	solution	were	added	and	incubated	for	30	min	in	the	dark	at	room	temperature.	





mRNA	was	extracted	by	using	 the	RNeasy	Plus	Mini	 kit	according	 to	 the	manufacturer’s	
































































































In	 order	 to	 obtain	 high	 amount	 of	 DNA,	 bacteria	 were	 picked	 up	 and	 cultured	 in	 3	ml	
ampicillin	 LB	medium	 overnight	 at	 37	 °C	 with	 shaking	 at	 180	 rpm.	 Then	 bacteria	 were	
transferred	into	300	ml	ampicillin	LB	medium	and	cultured	overnight	at	37	°C	with	shaking	
































used	 as	 APCs.	 Briefly,	 T	 cells	 were	 resuspended	 in	 2	ml	 EH	 and	 then	 overlaid	 on	 2	ml	
Nycoprep	 in	a	15	ml	Falcon	tube	followed	by	centrifuging	at	675	g	 for	10	min	with	mild	
brake.	The	2	ml	interface	between	Nycoprep	and	EH	were	taken	out	and	washed	with	15	














instruction.	The	concentration	of	 the	 total	RNA	was	evaluated	by	using	 the	Agilent	RNA	
6000	Pico	kit	according	to	manufacturer’s	instruction	on	an	Agilent	2100	bioanalyzer.	mRNA	







was	 used	 to	 identify	 the	 enriched	 gene	 sets	 in	 sequencing	 data	 by	 running	 against	 the	
Molecular	Signature	Database	(MSigDB)	(Subramanian,	Tamayo	et	al.	2005).	
2.2.10 	Statistical	analysis	






































The	activation	 sensor	NFAT-GFP	 in	CD4+	T	 cells	 translocates	within	a	 few	minutes	when	
T	cells	get	stimulation	and	has	been	used	to	visualize	the	activation	of	T	cells	in	real	time	
(Pesic,	Bartholomaus	et	al.	2013).	In	addition,	GFP	allows	tracking	of	the	T	cells	both	in	vitro	




which	 is	 detected	 by	 NFAT-GFP	 translocation.	 In	 this	 co-culture	 system,	microglia	 were	























By	 using	 this	 in	 vitro	 co-culture	 system,	 we	 evaluated	 the	 T	 cell	 activation	 capacity	 of	
microglia	under	different	conditions.	We	imaged	every	30	sec	for	30min	and	quantified	T	
cell	activation.	Around	4%	TMBP-NFAT-GFP	cells	underwent	NFAT-GFP	translocation	when	they	
were	 co-cultured	 with	 non-treated	 microglia	 from	 naive	 rats,	 indicating	 that	 quiescent	
microglia	alone	hardly	induced	TMBP-NFAT-GFP	cell	activation	(Fig.	3.1.2	C).	Therefore,	we	asked	
whether	 activated	microglia	 could	 induce	 T	 cell	 activation.	 First,	we	used	 LPS	 to	 induce	












with	 TMBP-NFAT-GFP	 cells.	 Interestingly,	 the	 results	 showed	 that	 MBP	 alone	 increased	 the	
proportion	of	activated	T	cells	from	4%	to	42%	(Fig.	3.1.2	C).	Moreover,	the	addition	of	MBP	
also	enhanced	the	T	cell	activation	capacity	of	LPS/IFN-γ-stimulated	microglia.	Among	all	















these	 treatments	 significantly	 increased	 T	 cell	 activation	 upon	 following	 co-culture	 (Fig.	
3.1.2).	This	discrepancy	is	discussed	later	(section	4.1).	In	contrast,	IFN-γ	enhanced	MHCII	
expression	dramatically,	which	is	in	line	with	the	T	cell	activation	capacity	of	the	pre-treated	
microglia.	 Taken	 together,	 quiescently	 cultured	microglia	 cannot	 induce	 TMBP-NFAT-GFP	 cell	


















(100	 ng/ml),	 OVA	 (10	 µg/ml)	 or	 a	 combination	 of	 both.	Means	 +/-	 S.E.M	 of	 three	 independent	
experiments,	**p	<	0.01,	***p	<	0.001,	unpaired	t	test.	
TOVA-NFAT-GFP	 cells	 were	 similar,	 it	 is	 unlikely	 that	 contaminating	 MBP	 influenced	 T	 cell	
activation.	More	importantly,	the	results	suggest	the	antigen-independent	activation	of	T	
cells	by	microglia	which	is	regulated	by	IFN-γ.	Same	as	in	the	MBP	condition,	OVA	treated	






























































(MG+MBP)	 directly.	 Representative	 data	 (B,	 C)	 and	 means	 +/-	 S.E.M	 (D)	 of	 three	 independent	
experiments.	
(Fig.	 3.1.6	B).	 The	purity	of	microglia	 and	macrophages	was	assessed	by	 flowcytometry,	
which	showed	more	than	95%	purity	in	both	microglia	and	macrophages	(Fig.	3.1.6	C).	The	
purified	microglia	and	macrophages	were	further	cultured	for	6	days	and	were	used	for	co-
culture	with	T	 cells	 and	 following	 imaging	 (Fig.	 3.1.6	D).	 Interestingly,	 in	 the	absence	of	
exogenous	 MBP,	 we	 found	 that	 macrophage	 alone	 activated	 70%	 of	 TMBP-NFAT-GFP	 cells,	








Figure	 3.1.2.	 Taken	 together,	 in	 the	 acute	 phase	 of	 EAE,	 CNS-infiltrated	 macrophages	






















the	 T	 cells.	 Therefore,	 to	 understand	whether	 T	 cell	 activation	 observed	 in	 imaging	 can	
change	 gene	 expression	 of	 T	 cells,	we	 co-cultured	 T	 cells	with	microglia	 for	 24	 hrs	 and	
analyzed	 their	 RNA	 and	 protein	 expression	 profiles.	 At	 first,	we	 looked	 at	 IFN-γ	 protein	
expression	 in	 the	 T	 cells,	 as	 a	 key	 cytokine	 which	 is	 expressed	 after	 T	 cell	 activation.	










cells).	 IFN-γ	 was	 analyzed	 by	 intracellular	 staining.	 TMBP-GFP/TOVA-GFP	 cells	 stained	 with	 secondary	
antibodies	 (Ab)	 only	were	 used	 for	 gating.	 The	 results	 are	 representative	 of	 three	 independent	





(Fig.	3.2.1	A	and	B).	To	 test	 the	antigen	dependency	of	 IFN-γ	 induction	by	microglia,	we	
RESULTS	
	 61	















after	 adoptive	 transfer	 (Schlager,	 Korner	 et	 al.	 2016).	 Since	 this	 time	 point	 is	 before	














Fig.	 3.3.1|	Microglia	 induce	pro-inflammatory	 cytokine	 expression	 in	 TMBP	 cells.	 A,	 B.	 The	mRNA	












times	more	 Ifng,	2	 times	more	Tnf	and	50	times	more	 Il1b	as	compared	to	the	negative	
control	 (Fig.	3.3.1	B).	Of	note,	after	co-culturing	with	microglia	for	48	hrs,	although	 Ifng,	





high	 potential	 to	 stimulate	 T	 cells.	 In	 contrast	 to	 inflammatory	 cytokines,	 comparable	
expression	 levels	 of	 Treg	 or	 TH17	 cytokines,	 such	 as	 Il6	 and	 Il23a,	 were	 observed	 in	 all	
conditions,	indicating	that	expression	of	these	cytokines	is	not	regulated	by	microglia.	GM-





to	 regulate	 myeloid	 cells	 to	 produce	 IL-1β	 (Jain,	 Irizarry-Caro	 et	 al.	 2020).	 We	 did	 not	
observe	an	upregulation	of	Fasl	in	TMBP	cells	after	co-culturing	with	microglia	or	thymocytes	
(Fig.	 3.3.1	 A	 and	 B).	 Taken	 together,	 microglia	 were	 strong	 regulators	 of	 inflammatory	
cytokines	 in	 TMBP	 cells	 in	 an	 antigen-independent	manner.	 These	 upregulated	 cytokines	
might	 play	 a	 role	 in	 promoting	 the	 inflammatory	 cascade	 at	 the	 early	 phase	 of	 EAE.	 In	










cultured	 with	 microglia.	 For	 example,	 Ifng,	 Il17a	 and	 Il1b	 expression	 were	 significantly	
upregulated	and	a	trend	towards	an	increase	of	Tnf	was	observed	(Fig.	3.3.2).	Also,	like	in	









As	 shown	 above,	microglia	 induced	 cytokine	 expression	 in	 T	 cells.	 Therefore,	 we	 could	
hypothesize	that	T	cells	change	microglia	phenotype.	To	answer	this	question,	we	evaluated	
gene	expression	of	Il1b,	Il6	and	Tnf	in	microglia	after	co-culturing	with	TMBP	cells	for	24	hrs	






anti-CD3	and	anti-CD28	antibodies	 (Jain,	 Irizarry-Caro	et	 al.	 2020).	 In	 contrast,	microglia	












that	 its	 expression	 is	 slightly	 increased	 after	 co-culturing	with	 T	 cells	 (Fig.	 3.3.3).	MD-1,	
encoded	 by	 the	 gene	 LY86,	 forms	 a	 complex	 with	 radioprotective	 105	 kDa	 protein	 to	





































hrs	 and	 48	 hrs.	 Strikingly,	 flowcytometry	 analysis	 showed	 that	 microglia	 substantially	
induced	 OX-40	 and	 IL-2R	 expression	 on	 TMBP	 cells	 to	 a	 comparable	 extent	 as	 fully	


























































the	CNS	which	 further	 lead	to	the	 formation	of	 local	 inflammation	 (Mundt,	Greter	et	al.	
2019).	Therefore,	we	looked	at	the	infiltration	of	macrophages	in	spinal	cord	parenchyma,	
however,	we	did	not	observe	infiltration	of	peripheral	macrophage	into	CNS	of	recipients	


















Among	 the	pronounced	upregulated	 genes,	 two	 innate	 cytokines	Tnf	 and	 Il1b	 drew	our	
attention	 (Fig.	 3.3.1	 and	 Fig.	 3.3.2).	 TNF	 signaling	 was	 found	 play	 an	 important	 role	 in	
regulating	IFN-γ	production	in	CD4+	T	cells	and	IL-1b	production	in	myeloid	cells	(Chou,	Tsai	
et	 al.	 2001,	 Jain,	 Irizarry-Caro	 et	 al.	 2020).	 Therefore,	 here	we	 asked	whether	microglia	
regulated	 T	 cell	 activation	 via	 TNF-α,	which	 acts	 on	 T	 cells	 in	 an	 autocrine	 or	 paracrine	
manner.	 In	 order	 to	 answer	 this	 question,	we	 used	 TNF-α	 deficient	 TMBP	 cells.	We	 took	




















IFN-γ	 and	 relatively	 higher	 amount	 of	 IL-1β	 (Fig.	 3.7.2).	 Co-culturing	with	microglia,	 the	
expression	of	all	those	cytokines	were	dramatically	upregulated	in	sgNT-TMBP-Cas9-EGFP	cells	

























was	 retrovirally	 delivered	 into	 TMBP-Cas9-EGFP	 cells.	 IL1R1	 knockout	 efficiency	 of	 four	 sgRNAs	 was	




























rats	 and	 naive	 rats	 and	 from	 spleen	 of	 naive	 rats	 were	 stained	 for	 CD11b	 and	 CD45.	Microglia	




Volcano	 plot	 displayed	 1035	 upregulated	 genes	 and	 1035	 downregulated	 genes	 among	
9484	detected	genes	in	microglia	from	EAE	rats	compared	to	microglia	from	naive	rats;	914	
upregulated	 genes	 and	 714	 downregulated	 genes	 among	 8974	 detected	 genes	 in	
macrophages	from	EAE	rats	compared	to	macrophages	from	the	spleens	of	naive	rats	(cut	
off	fold	change	2,	p	value	0.01)	(Fig.	3.9.2).	The	results	showed	that	chemokines	such	as	
















GSEA	 showed	 that	 microglia	 from	 EAE	 rats	 displayed	 significant	 enrichment	 of	 IFN-γ	
signaling	compared	to	microglia	from	naive	rats.	Notably,	a	group	of	genes	related	to	IFN-γ	
response	 (e.g.,	 Cxcl9-11,	 Cd74,	 Ccl5,	 Irf1	 and	 Vcam1;	 Fig.	 3.9.3	 A)	 were	 significantly	
upregulated,	indicating	that	TH1	cells	induce	microglia	activation	during	the	early	stage	of	
EAE.	In	addition,	GSEA	identified	enriched	genes	that	participate	in	cytokine	and	receptor	
interaction,	 which	 may	 help	 us	 to	 understand	 the	 mechanism	 of	 T	 cell	 and	 microglia	
interaction.	 Of	 note,	 microglia	 significantly	 upregulated	 receptor	 Il2rg	 which	 is	 known	
important	for	maintaining	T	cell	homeostasis	(Fig.	3.9.3	B)	(Rochman,	Spolski	et	al.	2009).	
Furthermore,	chemokines	such	as	Cxcl9,	10,	11	and	Ccl5	were	significantly	upregulated	in	
microglia	 from	 EAE	 rats	 compared	 to	 microglia	 from	 naive	 rats.	 Those	 cytokines	 were	
important	for	recruiting	TMBP	cells	which	express	corresponding	chemokine	receptor	such	
as	CXCR3,	CCR5	and	CXCR4	into	the	CNS	during	EAE	development	(Schlager,	Korner	et	al.	
2016).	 This	 indicated	 that	 at	 early	 stage	 of	 EAE,	 TH1	 cells	 instruct	 microglia	 to	 secret	
chemokines	which	further	recruit	more	T	cells	infiltration.	Moreover,	we	looked	at	the	top	


























Fig.	3.9.3	Gene	expression	 in	microglia	and	macrophages	 from	EAE	 rats.	Differentially	expressed	
genes	 of	 microglia	 from	 EAE	 rats	 were	 queried	 against	 hallmark	 gene	 sets	 (A)	 or	 c2.	 canonical	



























to	 study	 the	 antigen	 presenting	 function	 of	 microglia	 by	 focusing	 on	 the	 interaction	
between	 microglia	 and	 encephalitogenic	 T	 cells	 during	 the	 development	 of	 CNS	
inflammation.		
There	are	still	some	technical	difficulties	in	identifying	the	critical	APCs	in	the	CNS	during	
EAE	 development.	 Bone	 marrow	 chimeras	 are	 often	 used	 to	 replace	 a	 particular	 cell	
population	in	the	CNS.	However,	due	to	irradiation,	the	tightness	of	BBB	is	not	as	same	as	
it	 is	 in	 naive	 animals.	 The	 BBB	 often	 becomes	 leaky	 and	 thus	 more	 immune	 cells	 can	
penetrate	into	the	CNS	(Mildner,	Schmidt	et	al.	2007).	In	addition,	the	immunization	with	
CFA,	 which	 is	 often	 used	 to	 induce	 active	 EAE,	 also	 affects	 the	 landscape	 of	 the	 CNS	
(Raghavendra,	 Tanga	et	al.	 2004).	 Therefore,	 these	 treatments	may	create	difficulties	 in	
distinguishing	 the	 CNS-resident	 cells	 from	 the	 CNS-invading	 myeloid	 cells	 due	 to	







At	 the	 same	 time,	 it	 is	 also	difficult	 to	 interpret	 the	 findings	due	 to	 their	 complexity	 as	
described	 above.	 Therefore,	 in	 this	 study,	 we	 used	 an	 in	 vitro	 co-culture	 system	 with	
primary	 microglia	 and	 CNS	 antigen-specific	 CD4+	 T	 cells.	 Unlike	 the	 traditional	 way	 of	
culturing	microglia,	which	is	acquiring	microglia	from	postnatal	day	1	rats,	we	challenged	






macrophages	 (Fig.	 3.1.1).	 The	 microglia	 can	 be	 kept	 in	 culture	 for	 days	 with	 ramified	
morphology	and	can	be	labeled	with	fluorescence-conjugated	IB4,	which	enables	to	record	







By	using	our	 in	 vitro	 co-culture	 system,	we	examined	T	 cell	 activation	by	microglia.	 The	
imaging	data	 revealed	 that	microglia	 from	naive	 rats	do	not	activate	T	cells.	We	 further	
asked	whether	activated	microglia	were	able	to	activate	TMBP	cells.	Here,	LPS	were	used	to	
induce	microglia	 activation.	Bacterial	 LPS	are	highly	 conserved	among	microbes	and	are	
recognized	 by	 TLR4	 (Miller,	 Ernst	 et	 al.	 2005).	 The	 binding	 of	 LPS	 to	 TLR4	 induces	 the	






enhanced	 ability	 to	 activate	 TMBP	 cells.	 The	 enhanced	 ability	 was	 correlated	 with	
upregulation	 of	MHCII	 on	microglia,	 indicating	 that	 IFN-γ	 instead	 of	 LPS	 induces	MHCII	
expression	 and	 thus	 the	 antigen	 presenting	 function	 of	 microglia	 which	 is	 in	 line	 with	




shown	 to	 stimulate	 microglia	 and	 thus	 enables	 microglia	 to	 acquire	 higher	 antigen	
presenting	capacities	 (Aloisi,	Ria	et	al.	2000).	Therefore,	microglia	can	contribute	 to	EAE	
















preparation.	 As	 expected,	 we	 did	 not	 observe	 upregulation	 of	 MHCII	 by	 MBP.	 The	
observation	of	a	significantly	increased	capacity	of	MBP/OVA	treated	microglia	in	activating	








phase	 of	 EAE.	 After	 adoptive	 transfer	 of	 T	 cells	 into	 recipient	 rats,	 the	 first	 few	 T	 cells	
penetrate	into	the	CNS	within	some	hrs	(Hickey,	Hsu	et	al.	1991,	Odoardi,	Sie	et	al.	2012).	
At	this	time	point,	the	infiltration	of	peripheral	macrophages	has	not	started	yet.	A	previous	
study	 from	 our	 lab	 showed	 that	 meningeal	 perivascular	 macrophages	 can	 present	






phagocytes	 substantially	 induced	 both	 TMBP	 and	 TOVA	 cell	 activation	 even	 without	 the	
addition	of	antigen.	Anti-MHCII	blocking	antibodies	reduced	the	proportion	of	activated	T	
cells	 to	a	similar	extent	as	observed	by	naive	microglia	 (Figs.	3.1.2	C,	3.1.4	and	3.1.5	B).	
However,	 on	 the	 one	 hand,	 phagocytes	 activated	 TOVA	 cells	 without	 presence	 of	 their	
cognate	antigen;	on	 the	other	hand,	blocking	MHCII	 reduced	TOVA	 cell	 activation,	 seems	
contradictory.	 In	 addition	 to	 the	 classical	 antigen	 presenting	 function,	 it	 has	 been	
speculated	 that	 MHCII	 can	 function	 as	 receptor	 to	 mediate	 cytokine	 production,	 cell	










but	 they	 do	 not	 get	 activated	 within	 the	 CNS	 and	 they	 cannot	 induce	 EAE.	 When	 co-
transferred	with	TMBP	cells,	which	open	the	BBB,	TOVA	cells	can	penetrate	into	the	CNS	in	
massive	numbers.	 Still,	 TOVA	 cells	do	not	get	activated	 (Flugel,	Berkowicz	et	al.	 2001).	 In	
addition,	the	imaging	of	T	cells	 in	acute	spinal	cord	slices	showed	that	compared	to	TMBP	
cells,	 TOVA	 cells	 moved	 in	 the	 spinal	 cord	 parenchyma	 with	 higher	 motility	 and	 lower	
meandering	index,	suggesting	TOVA	cells	do	not	stop	in	the	proximity	of	APCs	(Kawakami,	
Nagerl	 et	 al.	 2005).	 By	 using	 the	 calcium	 sensing	 protein	 Twitch1,	 which	 fluorescently	
indicates	changes	of	intracellular	calcium	concentration	as	a	result	of	T	cell	activation,	our	
lab	 showed	 that	 less	 than	 1%	 of	 TOVA-Twich1	 cells	 emitted	 high-calcium	 signals	 at	 the	









OX-40	on	 TOVA	 cells	 in	 Fig.	 3.4.1	 is	 contradictory	 to	 the	 previous	 observation	 that	 those	
markers	were	not	upregulated	(Flugel,	Berkowicz	et	al.	2001).	This	might	be	explained	by	








In	 this	 thesis,	we	showed	 that	direct	 contact	 seems	 to	be	necessary	 (Fig.	3.3.4)	and	 the	
contribution	 of	 MHCII	 (Fig.	 3.1.5).	 The	 molecular	 mechanisms	 of	 antigen-independent	
activation	 need	more	 studies,	 especially	MHCII	 independent	mechanisms.	 For	 example,	





is	 not	 sufficient	 to	 induce	 NFAT	 translocation	 by	 itself,	 but	 sufficient	 to	 change	 T	 cell	
phenotypes	 (Kyratsous,	 Bauer	 et	 al.	 2017).	 In	 addition,	 such	 weak	 signals	 can	 be	
accumulated	to	induce	NFAT-GFP	translocation.	In	combination,	we	could	delete	molecules	
which	are	speculated	to	be	involved	in	the	signaling	cascade	of	T	cell	activation	by	using	

















in	 absence	 of	 exogenous	 MBP	 was	 comparable	 to	 fully	 restimulated	 TMBP	 cells	 in	 the	
presence	of	MBP.	These	molecules	are	considered	as	activation	markers	of	CD4+	T	cells.	In	
addition,	OX-40	is	a	costimulatory	molecule	which	belongs	to	the	TNFR	super	family	and	is	
important	 for	 CD4+	 T	 cell	 differentiation,	 expansion	 and	 survival	 (Redmond,	 Ruby	 et	 al.	
2009).	Some	evidences	suggest	that	costimulatory	signals	alone	can	activate	CD4+	T	cells	









During	 EAE,	 peripheral	 macrophages	 infiltrate	 into	 the	 CNS,	 therefore	 the	 cultured	
phagocytes	 isolated	 from	 the	CNS	of	EAE	 rats	 contain	both	 infiltrated	macrophages	and	
microglia.	 Our	 results	 showed	 that	 microglia	 were	 less	 effective	 in	 inducing	 TMBP	 cell	
activation	 compared	 to	 macrophages	 (Fig.	 3.1.6).	 However,	 microglia	 do	 induce	 T	 cell	
activation	and	can	contribute	to	T	cell	activation,	which	can	be	important	in	the	early	phase	
of	 EAE	 before	 peripheral	 macrophages	 infiltrate	 as	 discussed	 above.	 The	 differences	





the	 proportion	 of	 activated	 TMBP-NFAT-GFP	cells	 by	microglia	 from	EAE	 rats	 (Fig.	 3.1.6)	was	





In	 the	 live	 imaging	 experiments	 to	 observe	 CD4+	 T	 cells	 co-cultured	with	microglia,	 the	
recording	 time	 period	 per	 imaging	 window	 was	 30	 minutes	 after	 pooling	 the	 two	 cell	
populations.	Such	a	short	period	is	sufficient	to	detect	the	activation,	which	is	indicated	by	








In	 addition	 to	 IFN-γ	 and	 IL-17,	 the	 innate	 cytokines	 TNF-a	 and	 IL-1b	 were	 also	 highly	





culture	 system.	 This	 observation	 is	 in	 line	 with	 a	 previous	 study	 identifying	 infiltrated	
macrophages	 instead	of	microglia	as	the	main	producer	of	 IL-1b	 (Vainchtein,	Vinet	et	al.	
























(Mundt,	 Greter	 et	 al.	 2019).	 Although	 astrocytes	 can	 express	 MHCII	 following	 IFN-γ	









It	 is	 interesting	 to	 notice	 that	 microglia	 instructed	 CD4+	 T	 cells,	 whereas	 microglia	
themselves	 did	 not	 show	dramatic	 changes	 upon	 co-culture.	 These	 results	 indicate	 that	
CD4+	T	cells,	but	not	microglia,	were	the	main	producers	of	TNF-a	and	IL-1b	in	the	co-culture	
system.	CD4+	T	cells	express	receptors	for	both	TNF-a	and	IL-1b	 (Croft	2009).	Therefore,	




T	 cells,	RNA-seq	was	applied	 to	characterize	 the	 transcriptome	profile	of	microglia	 from	
naive	and	EAE	rats.	The	EAE	rats	we	used	here	were	three	days	post	adoptive	transfer	of	
fully	 restimulated	TMBP	cells.	At	 this	 time	point,	 the	rats	showed	partial	paralysis	of	hind	
limbs,	indicating	massive	inflammation	in	the	CNS.	In	this	rat	EAE	model,	TMBP	cells	infiltrate	
into	the	CNS	in	two	waves.	The	first	wave	happens	within	first	few	hrs	after	transfer.	The	T	
cells	 in	 the	 first	 wave	 do	 not	 have	 any	 clinical	 effects	 and	 do	 not	 recruit	 peripheral	
macrophages	into	the	CNS	but	prepare	the	CNS	milieu	to	a	pro-inflammatory	condition.	The	
second	wave,	which	is	more	aggressive,	happens	three	to	four	days	after	transfer	(Hickey,	
Hsu	et	al.	 1991).	 In	 the	 second	wave,	massive	amounts	of	T	 cells	 infiltrate	 into	 the	CNS	
followed	by	macrophages	 (Kawakami,	Lassmann	et	al.	2004).	 Indeed,	 the	microglia	 from	
EAE	rats	were	prepared	after	second	wave	of	T	cell	infiltration.	RNA-seq	showed	enriched	
genes	in	IFN-γ	signaling	pathways	in	microglia	from	EAE	rats	compared	to	those	from	naive	
rats,	 indicating	 that	microglia	 also	 respond	 to	 T	 cell	 derived	 signals	 in	 vivo.	 As	 a	 result,	
microglia	dramatically	upregulated	chemokines	to	further	recruit	more	 lymphocytes	 into	



















Supplementary	 table	 1:	 Upregulated	 genes	 in	 microglia	 from	 EAE	 rats	 compared	 to	
microglia	from	naive	rats.	Cut	off	FC	is	20.	
Gene	Name	 Log2(FC)	 -Log10(P-value)	 -Log10(P-adj)	
Cxcl9	 9.28	 84.64	 81.95	
Il2rg	 8.73	 46.59	 44.26	
Cd3d	 8.62	 26.15	 24.28	
Arhgef3	 8.51	 25.31	 23.46	
Cd2	 8.50	 19.31	 17.62	
Cxcl11	 8.23	 168.86	 165.76	
RT1-Da	 8.17	 305.65	 301.94	
Il2rb	 8.06	 16.54	 14.95	
Kcnn4	 8.06	 26.47	 24.59	
Cxcl10	 8.04	 305.23	 301.70	
Cxcr3	 7.86	 24.01	 22.19	
Gda	 7.81	 58.27	 55.77	
Ass1	 7.72	 69.11	 66.49	
Msr1	 7.64	 18.37	 16.70	
Cd247	 7.57	 13.83	 12.33	
RT1-Ba	 7.56	 266.36	 262.96	
Cnn3	 7.46	 17.34	 15.72	
Ccl5	 7.40	 34.96	 32.87	
Prr5l	 7.36	 16.66	 15.06	
Cd3e	 7.34	 16.35	 14.76	
Skap1	 7.33	 12.75	 11.30	
Fabp5	 7.31	 16.25	 14.67	
RT1-Bb	 7.29	 22.47	 20.67	
Il18rap	 7.21	 15.66	 14.11	
RT1-Db1	 7.13	 19.55	 17.85	
Trib3	 7.09	 14.90	 13.36	
Lck	 7.05	 14.58	 13.07	
Dusp2	 7.03	 17.77	 16.13	
Top2a	 7.03	 19.36	 17.66	
Socs1	 6.98	 31.54	 29.52	
Bcl3	 6.95	 14.07	 12.56	
Prf1	 6.93	 24.62	 22.78	
Adam19	 6.92	 13.68	 12.20	
Zbp1	 6.89	 10.69	 9.32	
Ubd	 6.86	 13.56	 12.08	
Iqgap1	 6.85	 10.59	 9.24	
Ctsw	 6.80	 10.37	 9.03	
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Gimap4	 6.75	 10.14	 8.81	
Ciita	 6.74	 19.67	 17.96	
Apol3	 6.73	 10.06	 8.73	
Lgals3	 6.72	 88.44	 85.74	
Serping1	 6.68	 159.22	 156.21	
Mt1	 6.61	 18.93	 17.25	
Sh2d2a	 6.59	 9.38	 8.09	
Zap70	 6.59	 9.46	 8.17	
Bcl11b	 6.58	 9.43	 8.14	
RGD1564664	 6.54	 9.35	 8.06	
Gpr171	 6.49	 11.49	 10.10	
RT1-DOa	 6.49	 13.44	 11.97	
Nkg7	 6.45	 19.81	 18.09	
Cd38	 6.37	 8.63	 7.38	
Mt2A	 6.34	 10.72	 9.35	
Ube2c	 6.30	 8.33	 7.09	
Tgm2	 6.30	 16.31	 14.72	
Upp1	 6.29	 12.49	 11.06	
Flt1	 6.25	 11.79	 10.39	
Fam111a	 6.21	 8.13	 6.91	
Itk	 6.18	 8.03	 6.81	
Fam102a	 6.18	 15.33	 13.78	
Acod1	 6.16	 7.95	 6.74	
Psat1	 6.09	 7.66	 6.47	
Gimap9	 6.08	 7.68	 6.49	
Gimap7	 6.05	 9.31	 8.02	
Tnfrsf4	 6.03	 7.53	 6.35	
P2ry10	 6.02	 7.51	 6.33	
Sit1	 6.01	 7.41	 6.24	
Il1r2	 5.98	 14.21	 12.70	
Adgrg5	 5.98	 7.36	 6.20	
B4galnt1	 5.95	 8.71	 7.46	
Mthfd1l	 5.93	 8.87	 7.60	
Il2ra	 5.93	 7.12	 5.96	
Hopx	 5.93	 11.75	 10.35	
Ifi44l	 5.88	 7.06	 5.90	
Mybl2	 5.80	 6.81	 5.67	
Lat	 5.78	 6.74	 5.61	
Crispld2	 5.75	 7.78	 6.58	
Icos	 5.74	 7.96	 6.75	
Vcam1	 5.74	 44.43	 42.12	
Cox6a2	 5.74	 12.28	 10.86	
Tnfrsf18	 5.73	 6.59	 5.46	
Ptgs2	 5.65	 6.38	 5.27	
Pstpip2	 5.61	 13.00	 11.54	
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Cdc42ep2	 5.60	 14.70	 13.17	
Pde4d	 5.60	 6.12	 5.02	
Lilrc2	 5.55	 7.36	 6.20	
Hk3	 5.52	 16.65	 15.05	
Cd44	 5.51	 13.18	 11.72	
Mcm5	 5.48	 19.01	 17.32	
Cd69	 5.47	 5.90	 4.82	
Olfm1	 5.45	 8.83	 7.56	
Ttr	 5.44	 5.79	 4.72	
LOC691141	 5.43	 31.62	 29.60	
Rftn1	 5.42	 9.98	 8.66	
Gng3	 5.42	 5.76	 4.69	
Ggt1	 5.38	 5.59	 4.54	
Patj	 5.33	 8.69	 7.44	
Diaph1	 5.32	 27.51	 25.61	
Ptges	 5.32	 6.46	 5.35	
Gbp2	 5.31	 180.58	 177.27	
Rora	 5.29	 5.45	 4.42	
Phgdh	 5.28	 7.25	 6.09	
Slc7a2	 5.22	 8.19	 6.96	
Gvin1	 5.21	 5.23	 4.21	
Tubb6	 5.21	 17.77	 16.13	
Il17re	 5.20	 5.23	 4.21	
Sod2	 5.17	 145.71	 142.75	
Ndrg1	 5.17	 20.30	 18.56	
Cdk1	 5.15	 5.12	 4.11	
Lgals1	 5.09	 4.97	 3.98	
Tnfrsf14	 5.09	 4.96	 3.96	
Csf2rb	 5.07	 4.91	 3.92	
Scimp	 5.07	 4.90	 3.91	
Spn	 5.05	 42.14	 39.88	
Tnfrsf9	 5.03	 4.83	 3.85	
LOC100359515	 5.01	 6.47	 5.35	
Ifi27l2b	 4.98	 29.11	 27.15	
Rasip1	 4.96	 4.69	 3.72	
Serpinb6b	 4.95	 6.08	 4.99	
Dok2	 4.94	 4.61	 3.65	
Slco3a1	 4.93	 4.62	 3.66	
Cyfip2	 4.88	 9.69	 8.38	
Tuba1c	 4.87	 5.12	 4.11	
Isg15	 4.83	 27.74	 25.82	
Cd3g	 4.78	 4.30	 3.36	
Ahnak	 4.73	 4.19	 3.26	
Ccr6	 4.72	 10.97	 9.59	
Prdx5	 4.72	 111.91	 109.08	
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Prxl2a	 4.72	 4.80	 3.82	
Stk39	 4.70	 4.15	 3.23	
Noct	 4.69	 4.11	 3.20	
Ramp1	 4.69	 4.10	 3.19	
Jaml	 4.65	 4.03	 3.13	
Gata3	 4.65	 5.70	 4.64	
Etv6	 4.64	 4.04	 3.14	
Igf2r	 4.63	 4.01	 3.12	
Rab11fip1	 4.62	 5.61	 4.56	
Bspry	 4.62	 4.00	 3.10	
Xdh	 4.61	 7.92	 6.72	
Sfxn1	 4.59	 4.43	 3.48	
Wdhd1	 4.58	 3.92	 3.03	
Cish	 4.57	 3.90	 3.02	
Spp1	 4.57	 12.11	 10.69	
Cdkn1a	 4.56	 51.45	 49.05	
MGC105649	 4.55	 22.57	 20.77	
Crip1	 4.54	 13.40	 11.93	
Eml2	 4.54	 3.84	 2.96	
Slfn4	 4.52	 89.80	 87.07	
Psen2	 4.51	 56.40	 53.92	
Chchd10	 4.47	 16.14	 14.57	
Acap1	 4.46	 3.68	 2.82	
Ikzf3	 4.46	 3.68	 2.82	
Plvap	 4.46	 4.19	 3.27	
Fgl2	 4.43	 48.99	 46.63	
Birc3	 4.43	 4.11	 3.20	
Abitram	 4.40	 3.59	 2.74	
Irf1	 4.40	 178.60	 175.38	
Slc7a11	 4.39	 4.04	 3.14	
Ifitm1	 4.39	 40.00	 37.79	
Bcat1	 4.37	 4.87	 3.88	
Rell1	 4.34	 3.94	 3.05	
Cks1b	 4.34	 3.49	 2.65	
Irgm	 4.33	 18.79	 17.11	
Ptpn22	 4.32	 5.77	 4.70	
	
Supplementary	 table	 2:	 Downregulated	 genes	 in	 microglia	 from	 EAE	 rats	 compared	 to	
microglia	from	naive	rats.	Cut	off	FC	is	20.	
Gene	Name	 Log2(FC)	 -Log10(P-value)	 -Log10(P-adj)	
Usp35	 -7.66	 13.97	 12.47	
Pclo	 -7.65	 13.79	 12.30	
LOC102551819	 -7.64	 13.99	 12.49	
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Chd5	 -7.47	 12.78	 11.33	
Adgra2	 -7.31	 12.34	 10.92	
Kif21a	 -7.19	 11.68	 10.28	
Hspa1a	 -7.12	 24.68	 22.83	
Ankrd55	 -7.03	 10.90	 9.53	
Unc80	 -7.00	 10.85	 9.48	
Kalrn	 -6.96	 10.74	 9.36	
Shisa8	 -6.96	 10.62	 9.26	
Ston2	 -6.88	 10.38	 9.03	
Abca9	 -6.88	 10.42	 9.07	
Ednrb	 -6.82	 12.56	 11.13	
Ppfia4	 -6.70	 9.63	 8.33	
Ryr2	 -6.67	 9.37	 8.08	
Gnas	 -6.46	 10.55	 9.20	
Kcna2	 -6.41	 34.10	 32.03	
Tjp1	 -6.30	 8.21	 6.98	
Tsga10	 -6.16	 9.19	 7.91	
Nefh	 -6.08	 7.37	 6.20	
Trem2	 -6.05	 162.29	 159.24	
Myt1l	 -5.92	 9.22	 7.94	
Gal3st4	 -5.87	 75.76	 73.12	
Peg3	 -5.79	 9.89	 8.57	
Unc13b	 -5.78	 6.60	 5.47	
Dok5	 -5.70	 6.35	 5.24	
Enpp2	 -5.59	 6.05	 4.96	
Astn1	 -5.46	 34.38	 32.30	
Lef1	 -5.46	 7.56	 6.38	
Ppp1r12b	 -5.46	 5.71	 4.65	
Wdr66	 -5.40	 5.55	 4.51	
Dock4	 -5.36	 42.19	 39.92	
Serinc4	 -5.36	 5.48	 4.44	
Bnc2	 -5.35	 7.88	 6.67	
Cald1	 -5.35	 5.46	 4.42	
Numb	 -5.34	 10.19	 8.86	
Tek	 -5.33	 6.27	 5.16	
Tmem119	 -5.24	 30.46	 28.47	
Khdrbs2	 -5.21	 5.12	 4.11	
Ank2	 -5.17	 5.05	 4.05	
Fbxl20	 -5.14	 20.20	 18.46	
Msh5	 -5.14	 4.97	 3.98	
P2ry12	 -5.10	 61.95	 59.38	
Peli3	 -5.08	 6.19	 5.09	
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Wdsub1	 -5.06	 12.29	 10.87	
Siglec5	 -5.02	 27.25	 25.36	
Xkrx	 -5.01	 7.41	 6.24	
Klhl30	 -4.98	 5.84	 4.77	
Klf4	 -4.89	 36.20	 34.07	
Zfp799	 -4.88	 4.81	 3.83	
Acvr2b	 -4.86	 4.39	 3.45	
Crispld1	 -4.86	 7.60	 6.41	
Pmp22	 -4.86	 4.34	 3.40	
Trim2	 -4.85	 5.81	 4.74	
Alpk2	 -4.83	 4.33	 3.39	
Itga9	 -4.83	 4.31	 3.37	
Cd84	 -4.82	 7.30	 6.14	
Syt1	 -4.79	 4.21	 3.29	
Treml1	 -4.76	 27.85	 25.93	
Camk2n1	 -4.76	 15.16	 13.61	
Brap	 -4.75	 4.16	 3.24	
Fmnl3	 -4.71	 6.46	 5.35	
Pamr1	 -4.70	 4.98	 3.98	
Rtn4rl1	 -4.69	 4.87	 3.88	
Ap3b2	 -4.67	 6.06	 4.97	
Gpbp1l1	 -4.67	 4.36	 3.42	
Col9a2	 -4.62	 3.91	 3.03	
Snhg11	 -4.62	 7.42	 6.24	
Cwh43	 -4.61	 3.90	 3.01	
Epb41l1	 -4.59	 3.88	 3.00	
Erp27	 -4.57	 4.95	 3.95	
Hcfc2	 -4.54	 3.79	 2.91	
Me3	 -4.54	 3.78	 2.91	
Ago3	 -4.54	 3.78	 2.90	
Med12l	 -4.53	 35.63	 33.51	
Col11a2	 -4.51	 3.73	 2.86	
Iqce	 -4.51	 3.72	 2.85	
Zfp579	 -4.50	 3.71	 2.85	
Slc18b1	 -4.47	 7.39	 6.22	
Dpp6	 -4.46	 26.09	 24.23	
Casc1	 -4.46	 3.59	 2.74	
Ttc26	 -4.46	 4.33	 3.40	
Dzip1	 -4.39	 4.98	 3.99	
Zmat1	 -4.39	 15.69	 14.13	
LOC103691310	 -4.36	 3.47	 2.63	
Coq8a	 -4.34	 3.44	 2.60	
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Arhgap20	 -4.33	 3.44	 2.60	
Per3	 -4.32	 4.47	 3.52	
	
Supplementary	 table	 3:	 Upregulated	 genes	 in	macrophages	 from	 EAE	 rats	 compared	 to	
macrophages	from	naive	rats.	Cut	off	FC	is	20.	
Gene	Name	 Log2(FC)	 -Log10(P-value)	 -Log10(P-adj)	
Slc7a2	 10.03	 23.92	 22.01	
Ca4	 9.91	 23.10	 21.20	
Sdc1	 9.64	 29.20	 27.19	
Ccl2	 9.56	 20.78	 18.95	
A3galt2	 9.27	 33.00	 30.89	
Ptges	 9.19	 32.40	 30.32	
Mt2A	 9.14	 18.27	 16.54	
Cish	 8.67	 21.62	 19.77	
Lhfpl2	 8.53	 14.95	 13.33	
Egr2	 8.48	 20.20	 18.40	
Maff	 8.46	 14.36	 12.77	
Vdr	 8.13	 13.07	 11.51	
Fabp5	 7.98	 142.16	 138.79	
Cxcl11	 7.96	 25.01	 23.07	
Thbs1	 7.83	 15.70	 14.05	
Sdc4	 7.61	 29.23	 27.20	
Acod1	 7.40	 86.79	 83.99	
Chac1	 7.24	 9.18	 7.77	
Htra1	 7.23	 9.39	 7.97	
Cxcl2	 7.18	 8.40	 7.05	
Ccl7	 7.17	 12.17	 10.64	
Tgm2	 7.05	 203.96	 200.46	
Gpr84	 6.98	 55.85	 53.43	
Arg1	 6.98	 7.89	 6.57	
Ass1	 6.96	 248.12	 244.44	
Ccl12	 6.77	 7.77	 6.46	
Socs1	 6.68	 46.32	 44.01	
Mt1m	 6.65	 7.46	 6.16	
Bcl2l1	 6.60	 16.73	 15.05	
Ccl22	 6.55	 15.55	 13.91	
Mmp7	 6.44	 6.85	 5.60	
Serpine1	 6.38	 10.17	 8.73	
Csf2rb	 6.31	 6.49	 5.27	
Ch25h	 6.23	 12.13	 10.61	
Cnn3	 6.22	 61.19	 58.68	
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Sema3c	 6.22	 6.27	 5.06	
Apol9a	 6.21	 6.26	 5.06	
Atxn1l	 6.20	 6.22	 5.02	
Cxcl3	 6.18	 6.16	 4.96	
Defb52	 6.12	 6.01	 4.82	
Scimp	 6.08	 20.07	 18.29	
Cd14	 6.07	 37.61	 35.39	
Cxcl9	 6.05	 108.06	 105.17	
Nrg1	 5.95	 5.61	 4.45	
Clic4	 5.94	 8.26	 6.92	
Glipr2	 5.92	 8.09	 6.76	
B3galnt1	 5.90	 17.61	 15.91	
Cdkn1a	 5.87	 11.09	 9.61	
Lyrm1	 5.82	 5.31	 4.17	
Ereg	 5.77	 5.19	 4.06	
Kcnab1	 5.76	 5.18	 4.05	
Cxcl10	 5.75	 18.28	 16.55	
Hk3	 5.65	 29.13	 27.12	
Jdp2	 5.62	 5.97	 4.78	
Cgas	 5.62	 4.86	 3.77	
Fcrlb	 5.47	 4.57	 3.51	
Upp1	 5.44	 119.19	 116.17	
Wsb2	 5.42	 4.47	 3.42	
LOC100359515	 5.41	 5.53	 4.38	
F3	 5.38	 4.34	 3.29	
Rnase10	 5.36	 4.35	 3.31	
Jag1	 5.35	 9.81	 8.38	
Klrk1	 5.35	 13.93	 12.35	
S100b	 5.35	 5.12	 4.00	
Il2ra	 5.32	 4.30	 3.25	
Tcp11	 5.29	 4.25	 3.21	
Bmf	 5.28	 5.61	 4.45	
Mmp14	 5.28	 42.75	 40.48	
Nampt	 5.22	 128.89	 125.69	
LOC102553386	 5.22	 4.78	 3.69	
Inhba	 5.20	 4.07	 3.06	
Limk2	 5.17	 12.87	 11.32	
Niban2	 5.16	 81.87	 79.14	
Bhlhe40	 5.14	 9.24	 7.83	
Ltb4r	 5.11	 3.92	 2.92	
C1qtnf1	 5.08	 3.86	 2.88	
Gbp5	 5.07	 74.40	 71.75	
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Mogat2	 5.06	 3.84	 2.85	
Slc41a2	 5.01	 3.74	 2.77	
Enpp3	 5.00	 6.66	 5.43	
Kdelr3	 4.98	 3.66	 2.70	
Fcgr2b	 4.96	 126.97	 123.84	
Ggn	 4.91	 3.57	 2.62	
Aldoc	 4.90	 4.08	 3.07	
Crem	 4.89	 32.85	 30.76	
Gbp2	 4.87	 134.07	 130.79	
Mreg	 4.86	 3.51	 2.57	
Actg1	 4.85	 3.49	 2.55	
Ccl3	 4.85	 10.55	 9.09	
Xaf1	 4.82	 4.16	 3.13	
Rxra	 4.77	 3.37	 2.44	
Il23a	 4.76	 3.35	 2.43	
Trib3	 4.76	 31.53	 29.47	
Ado	 4.70	 3.69	 2.72	
Pam	 4.70	 3.25	 2.34	
Osm	 4.69	 6.74	 5.50	
Ccl17	 4.66	 10.06	 8.62	
RGD1307182	 4.64	 3.19	 2.28	
Gfap	 4.62	 3.53	 2.59	
Lss	 4.60	 3.13	 2.23	
Il17a	 4.59	 3.10	 2.21	
Olr1	 4.58	 4.63	 3.56	
C2	 4.57	 3.08	 2.19	
Dok2	 4.56	 8.79	 7.42	
Il1a	 4.55	 5.38	 4.24	
Prr15	 4.54	 3.04	 2.16	
Ptgs2	 4.54	 6.15	 4.95	
Tnfaip3	 4.51	 3.40	 2.47	
Cdc42ep2	 4.49	 65.17	 62.59	
Cxcl1	 4.45	 2.91	 2.05	
Tubb6	 4.44	 38.72	 36.49	
Phlda1	 4.41	 6.98	 5.72	
Bcat1	 4.39	 122.51	 119.44	
Wfdc21	 4.38	 2.83	 1.98	
Nfkbid	 4.35	 4.45	 3.40	
Cd33	 4.35	 2.78	 1.94	
Ckap2l	 4.34	 3.06	 2.18	
Dusp2	 4.33	 20.31	 18.51	






Gene	Name	 Log2(FC)	 -Log10(P-value)	 -Log10(P-adj)	
Cd5l	 -10.78	 87.42	 84.55	
Fcgrt	 -9.99	 40.52	 38.27	
Cr2	 -9.94	 22.75	 20.86	
Fcmr	 -9.70	 34.35	 32.21	
Dnase1l3	 -9.33	 19.08	 17.32	
Gfra2	 -9.17	 17.69	 15.99	
Hpgds	 -9.13	 17.90	 16.19	
Gzma	 -8.72	 21.15	 19.32	
Ms4a1	 -8.48	 18.88	 17.12	
Hap1	 -8.37	 13.92	 12.34	
Rtn1	 -8.34	 18.29	 16.56	
Fabp4	 -8.33	 13.78	 12.20	
LOC100361706	 -8.18	 12.95	 11.40	
Plcb2	 -8.06	 18.98	 17.22	
Clic2	 -8.03	 20.08	 18.29	
Cd79b	 -8.02	 35.68	 33.51	
Gzmm	 -7.95	 16.21	 14.55	
Mzb1	 -7.93	 11.96	 10.44	
Tnfrsf13c	 -7.88	 11.74	 10.24	
Padi4	 -7.73	 11.07	 9.59	
Nrxn2	 -7.73	 11.11	 9.63	
Itgb5	 -7.70	 56.21	 53.77	
Adgrg3	 -7.70	 10.99	 9.51	
Ebf1	 -7.52	 13.31	 11.75	
Rnase11	 -7.40	 9.85	 8.42	
Fads1	 -7.40	 9.85	 8.42	
Rpgrip1	 -7.29	 9.01	 7.62	
Kcna2	 -7.25	 21.54	 19.70	
Dpp4	 -7.22	 9.13	 7.74	
Afap1l1	 -7.16	 8.98	 7.59	
Acss1	 -7.16	 8.93	 7.54	
Cd24	 -7.09	 11.30	 9.81	
Cdh1	 -7.06	 113.65	 110.71	
Clec4m	 -7.03	 8.50	 7.14	
Pdzd2	 -6.96	 8.30	 6.95	
Il22ra2	 -6.90	 8.08	 6.76	
Fcrl1	 -6.89	 8.08	 6.76	
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Slc9a9	 -6.85	 9.48	 8.06	
Gzmk	 -6.82	 18.23	 16.51	
Pitpnm2	 -6.79	 7.71	 6.41	
Dysf	 -6.77	 7.61	 6.31	
Igf1	 -6.70	 20.58	 18.77	
Hepacam2	 -6.65	 7.35	 6.07	
Agpat3	 -6.56	 12.03	 10.51	
Hba-a1	 -6.55	 7.05	 5.79	
Ccdc61	 -6.51	 6.81	 5.56	
Adora1	 -6.47	 6.86	 5.60	
Hbb-b1	 -6.46	 33.02	 30.90	
Ngfr	 -6.45	 17.82	 16.11	
Jmy	 -6.36	 6.53	 5.30	
Stk39	 -6.33	 6.47	 5.24	
Slamf7	 -6.26	 30.77	 28.73	
Slc45a3	 -6.26	 6.29	 5.08	
Slc8a1	 -6.26	 6.29	 5.08	
Tspan7	 -6.23	 7.36	 6.07	
Aebp1	 -6.19	 6.12	 4.92	
Frmd4b	 -6.19	 7.53	 6.24	
Trib2	 -6.15	 6.00	 4.81	
Zfp251	 -6.14	 5.98	 4.79	
Pxdc1	 -6.13	 5.96	 4.78	
Np4	 -6.13	 7.15	 5.88	
Cd27	 -5.99	 6.73	 5.49	
Mpped1	 -5.96	 5.56	 4.41	
Tnnt1	 -5.94	 6.56	 5.33	
Fancm	 -5.93	 5.42	 4.28	
Vcam1	 -5.92	 6.81	 5.56	
Hba1	 -5.91	 86.71	 83.94	
Rgs5	 -5.91	 5.40	 4.26	
Gcgr	 -5.90	 5.42	 4.27	
Gpr15	 -5.89	 5.36	 4.22	
Akap11	 -5.88	 7.39	 6.10	
Ust	 -5.87	 5.32	 4.18	
Bend5	 -5.85	 5.31	 4.17	
LOC100134871	 -5.78	 8.09	 6.76	
Madd	 -5.73	 4.98	 3.87	
Fcer2	 -5.73	 5.05	 3.93	
Unc79	 -5.71	 4.96	 3.85	
Cdip1	 -5.71	 5.00	 3.90	
Ncapd3	 -5.67	 4.88	 3.78	
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Lysmd4	 -5.64	 4.86	 3.77	
Cep162	 -5.64	 5.67	 4.51	
Spib	 -5.59	 7.25	 5.97	
Galnt6	 -5.57	 4.72	 3.64	
Jakmip1	 -5.54	 4.66	 3.59	
Heph	 -5.52	 9.87	 8.43	
Pip5k1b	 -5.52	 4.62	 3.55	
Ackr3	 -5.51	 4.57	 3.51	
Ptch1	 -5.48	 4.54	 3.48	
Ccr3	 -5.47	 36.19	 34.01	
Dchs1	 -5.47	 4.49	 3.43	
Sacs	 -5.46	 5.85	 4.67	
Ppfia4	 -5.45	 8.34	 7.00	
Iba57	 -5.44	 5.64	 4.48	
Ice2	 -5.41	 4.41	 3.36	
Ngp	 -5.40	 4.41	 3.36	
Carmil2	 -5.33	 4.26	 3.22	
Notch4	 -5.31	 4.22	 3.19	
Kcnk1	 -5.31	 4.22	 3.19	
Fstl3	 -5.29	 4.19	 3.15	
Ccdc180	 -5.29	 5.51	 4.36	
Timeless	 -5.28	 4.17	 3.14	
Tnik	 -5.28	 4.93	 3.83	
Syn1	 -5.27	 4.15	 3.12	
Klhdc1	 -5.25	 4.71	 3.63	
Arhgap21	 -5.25	 6.46	 5.24	
Dst	 -5.25	 20.59	 18.78	
Tenm2	 -5.24	 4.10	 3.08	
Cyp46a1	 -5.24	 4.09	 3.08	
Efnb3	 -5.22	 4.64	 3.57	
Pde3b	 -5.20	 4.75	 3.67	
Tnfrsf13b	 -5.16	 3.96	 2.96	
Mns1	 -5.13	 3.90	 2.91	
RT1-M2	 -5.12	 3.91	 2.91	
Vsx1	 -5.10	 3.86	 2.88	
Gpr174	 -5.07	 3.82	 2.84	
Gimap6	 -5.07	 3.82	 2.84	
Ankrd44	 -5.06	 5.79	 4.62	
Usp46	 -5.06	 4.28	 3.24	
Mical3	 -5.03	 4.20	 3.17	
Nav1	 -5.03	 3.69	 2.72	
Epb41l3	 -5.03	 9.95	 8.52	
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Art2b	 -5.03	 3.74	 2.77	
Reep6	 -5.02	 3.73	 2.76	
Lin9	 -4.99	 3.67	 2.71	
Togaram1	 -4.97	 3.62	 2.66	
Zfp397	 -4.94	 3.59	 2.64	
Ucp3	 -4.93	 4.16	 3.13	
Mks1	 -4.93	 3.56	 2.61	
S1pr3	 -4.92	 3.58	 2.63	
Cela1	 -4.90	 4.10	 3.08	
Slco2b1	 -4.90	 10.55	 9.09	
Cdca7l	 -4.90	 3.54	 2.59	
Cul9	 -4.88	 3.51	 2.57	
Arap2	 -4.88	 3.50	 2.57	
Cc2d2a	 -4.86	 3.48	 2.54	
Fcho1	 -4.86	 4.01	 3.00	
Kif5a	 -4.86	 3.42	 2.49	
Acy3	 -4.84	 3.44	 2.51	
Pgm2l1	 -4.83	 3.76	 2.78	
Lax1	 -4.82	 3.42	 2.49	
Niban3	 -4.78	 3.36	 2.43	
Zfp563	 -4.77	 3.70	 2.73	
Mtrf1l	 -4.77	 3.34	 2.42	
Defa5	 -4.75	 4.12	 3.10	
P2rx1	 -4.75	 3.32	 2.40	
RGD1306556	 -4.73	 3.28	 2.36	
Acp5	 -4.73	 34.44	 32.29	
Vsig8	 -4.72	 3.27	 2.36	
Ptbp2	 -4.69	 6.73	 5.49	
Txk	 -4.68	 3.22	 2.31	
Hba-a2	 -4.68	 55.60	 53.20	
Tmem209	 -4.67	 3.18	 2.28	
Rarres1	 -4.67	 8.35	 7.00	
Epcam	 -4.67	 3.19	 2.28	
Dennd2c	 -4.67	 3.19	 2.28	
Mmd	 -4.62	 3.12	 2.22	
Pla2g15	 -4.61	 20.80	 18.98	
Snap47	 -4.61	 3.10	 2.21	
Chaf1a	 -4.60	 4.66	 3.59	
Gimap8	 -4.58	 3.07	 2.19	
Bbs9	 -4.57	 3.06	 2.17	
Gse1	 -4.54	 2.97	 2.09	
Inf2	 -4.52	 5.14	 4.01	
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Pou2af1	 -4.52	 5.67	 4.50	
Ccr6	 -4.51	 12.21	 10.68	
Meis3	 -4.51	 2.97	 2.10	
Mis18bp1	 -4.51	 3.64	 2.68	
Mmp12	 -4.49	 3.44	 2.51	
Cd163	 -4.49	 3.52	 2.58	
Zfp296	 -4.48	 2.94	 2.07	
Pdgfc	 -4.48	 2.94	 2.07	
Fgf11	 -4.48	 2.93	 2.06	
Atp1b2	 -4.47	 2.93	 2.06	
Tmem9	 -4.46	 5.50	 4.36	
Akr1e2	 -4.45	 2.90	 2.03	
Retnlg	 -4.44	 3.54	 2.60	
Kiaa0408L	 -4.44	 2.87	 2.01	
Elmo1	 -4.41	 2.85	 1.99	
Cdhr1	 -4.41	 2.85	 1.99	
Tspan18	 -4.40	 2.83	 1.98	
Itsn1	 -4.39	 5.98	 4.79	
LOC688754	 -4.37	 2.76	 1.92	
Clec4a	 -4.36	 2.79	 1.94	
Tmcc2	 -4.34	 2.75	 1.91	
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